CTAD 2025 1 - 4 December 2025

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment

Authors :

Peter Johannsen¹; Marie Aare Bentsen¹; Dylan Matthew Belmont‑Rausch¹; Lisbeth Carstensen¹; Rose Jeppesen¹; Gabriel Martino¹; Martí Jiménez-Mausbach¹; Anne Börjesson-Hanson^2,3; Lotte Bjerre Knudsen¹

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Neurodegenerative diseases

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Semaglutide Concentration in Cerebrospinal Fluid from Patients with Early Alzheimer’s Disease After 12 Weeks of Subcutaneous Treatment